References
- Zhou HQ, Zhang FC, Tian XP, et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients. Lupus. 2008;17:93–99.
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheumatism. 1999 Apr;42(4):599–608. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10211873
- Cohen D, Rijnink EC, Nabuurs RJA, et al. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement. Rheumatology (Oxford). 2017;56:77–86.
- Postal M, Lapa AT, Reis F, et al. Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches. Lupus. 2017;26:517–521.
- Appenzeller S, Li LM, Costallat LTL, et al. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study. Brain. 2005 Dec;128(12):2933–2940. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16195241
- Appenzeller S, Li LM, Costallat LTL, et al. Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus. Lupus. 2007 Dec;16(12):963–971. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18042590
- Pamfil C, Fanouriakis A, Damian L, et al. EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology. 2015 Jul;54(7):1270–1278. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25638807
- Abe G, Kikuchi H, Arinuma Y, et al. Brain MRI in patients with acute confusional state of diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Mod Rheumatol. 2017 Mar;27(2):278–283. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27319397
- Hanly JG, Urowitz MB, Su L, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2010 Mar;69(3):529–535. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19359262 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2929162
- Appenzeller S, Cendes F, Costallat LTL. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study. Arthritis Rheumatism. 2009 May;61(5):680–687. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19405004
- Zirkzee E, Huizinga T, Bollen E, et al. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus. 2014 Jan;23(1):31–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24243776
- Vivaldo JF, de Amorim JC, Julio PR, et al. Definition of NPSLE: does the ACR nomenclature still hold? Front Med (Lausanne). 2018 May 5;138. Available from: https://www.frontiersin.org/article/10.3389/fmed.2018.00138/full
- Kampylafka EI, Alexopoulos H, Kosmidis ML, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS ONE. 2013 Feb;8(2):e55843.
- Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheumatism. 2007 Jan;56(1):265–273. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17195230
- Hanly JG, Su L, Farewell V, et al. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol. 2009 Jul;36(7):1449–1459. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15868618 http://www.ncbi.nlm.nih.gov/pubmed/19447937
- Sibbitt WL, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002 Jul;29(7):1536–1542. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12136916
- Stock AD, Gelb S, Pasternak O, et al. The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface. Autoimmun Rev. 2017 Jun;16(6):612–619. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28428121 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6068398 http://linkinghub.elsevier.com/retrieve/pii/S1568997217301052
- Kassan SS, Lockshin MD. Central nervous system lupus erythematosus. The need for classification. Arthritis Rheumatism. 1979 Dec;22(12):1382–1385. Available from: http://www.ncbi.nlm.nih.gov/pubmed/518720
- Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatism. 1982 Nov;25(11):1271–1277. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7138600
- How A, Dent PB, Liao SK, et al. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheumatism. 1985 Jul;28(7):789–795. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4015726
- Singer J, Denburg JA. Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. The ad hoc neuropsychiatric lupus workshop group. J Rheumatol. 1990 Oct;17(10):1397–1402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2254901
- Hanly JG. Evaluation of patients with CNS involvement in SLE. Bailliere’s clin rheumatol. 1998 Aug;12(3):415–431. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9890105
- Kovacs JA, Urowitz MB, Gladman DD. Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am. 1993 Nov;19(4):795–814. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8265823
- Ainiala H, Hietaharju A, Loukkola J, et al. Validity of the new American college of rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheumatism. 2001 Oct;45(5):419–423. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11642640
- Hanly JG, Kozora E, Beyea S, et al. Nervous system disease in systemic lupus erythematosus: current status and future directions. Arthritis Rheumatol. 2018 Jun. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29927108
- Hanly JG, Urowitz MB, Su L, et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheumatism. 2008 May;59(5):721–729. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18438902 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4656032
- Magro-Checa C, Zirkzee EJ, Beaart-van de Voorde LJJ, et al. Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort. Rheumatology. 2017 Oct;56(10):1676–1683. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28339952 http://academic.oup.com/rheumatology/article/56/10/1676/3058662/Valueof-multidisciplinary-reassessment-in
- Bortoluzzi A, Scire CA, Bombardieri S, et al. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology. 2015 May;54(5):891–898. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25339643 https://academic.oup.com/rheumatology/articlelookup/doi/10.1093/rheumatology/keu384
- Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004 Nov;31(11):2156–2162. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15517627
- Bortoluzzi A, Scirè CA, Govoni M. Attribution of neuropsychiatric manifestations to systemic lupus erythematosus. Front Med (Lausanne). 2018 Mar;5:68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29594125 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5861139 http://journal.frontiersin.org/article/10.3389/fmed.2018.00068/full
- Bortoluzzi A, Fanouriakis A, Appenzeller S, et al. Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study. BMJ open. 2017 May;7(5):e015546. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28554934 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5730002
- Hanly JG, Urowitz MB, Su L, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis. 2011 Oct;70(10):1726–1732. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21893582 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4664555
- Unterman A, Nolte JES, Boaz M, et al. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011 Aug;41(1):1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20965549
- Mitsikostas DD. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004 Feb;127(5):1200–1209. Available from: https://academic.oup.com/brain/articlelookup/doi/10.1093/brain/awh146
- Hanly JG, Urowitz MB, O’Keeffe AG, et al. Headache in systemic lupus erythemato-sus: results from a prospective, international inception cohort study. Arthritis Rheumatism. 2013 Nov;65(11):2887–2897. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24166793
- Hanly JG, Su L, Urowitz MB, et al. Mood disorders in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheumatol. 2015 Jul;67(7):1837–1847. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25778456 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4485527
- Huang X, Magder LS, Petri M, et al. Predictors of incident depression in systemic lupus erythematosus. J Rheumatol. 2014 Sep;41(9):1823–1833. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10685799 http://www.ncbi.nlm.nih.gov/pubmed/25128512
- Postal M, Appenzeller S. The importance of cytokines and autoantibodies in depression. Autoimmun Rev. 2015 Jan;14(1):30–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25242344 http://linkinghub.elsevier.com/retrieve/pii/S1568997214001967
- Aldar H, Lapa A, Bellini B, et al. Prevalence and clinical significance of antiribosomal P antibody in childhood-onset systemic lupus erythematosus. Lupus. 2012 Oct;21(11):1225–1231. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22740428
- Perricone C, Pendolino M, Olivieri M, et al. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus. Isr Med Assoc J. 2015 Mar;17(3):171–178. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25946769
- Postal M, Lapa AT, Sinicato NA, et al. Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus. J Neuroinflammation. 2016 Dec;13(1):5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26732584 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4702302 http://www.jneuroinflammation.com/content/13/1/5
- Ho RC, Thiaghu C, Ong H, et al. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. Autoimmun Rev. 2016 Feb;15(2):124–138. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26497108 http://linkinghub.elsevier.com/retrieve/pii/S156899721500213X
- Bogaczewicz J, Sob´Ow T, Bogaczewicz AR, et al. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosusa case report. Lupus. 2014 Feb;23(2):188–193. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24297641
- Saito T, Tamura M, Chiba Y, et al. Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder. J Neurol Sci. 2017 Aug;379:127–130. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28716225 http://linkinghub.elsevier.com/retrieve/pii/S0022510X17303659
- Buji RI, Abdul Murad NA, Chan LF, et al. Suicidal ideation in systemic lupus erythematosus: NR2A gene polymorphism, clinical and psychosocial factors. Lupus. 2018 Apr;27(5):744–752. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29161964
- Hajduk A, Nowicka-Sauer K, Smolen´Ska Z, et al. Prevalence and correlates of suicidal thoughts in patients with neuropsychiatric lupus. Lupus. 2016 Feb;25(2):185–192. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26359173
- Kozora E, Ellison MC, West S. Reliability and validity of the proposed American college of rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheumatism. 2004 Oct;51(5):810–818. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15478145
- Hanly JG, Omisade A, Su L, et al. Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests. Arthritis Rheumatism. 2010 May;62(5):1478–1486.
- Hanly JG, Su L, Omisade A, et al. Screening for cognitive impairment in systemic lupus erythematosus. J Rheumatol. 2012 Jul;39(7):1371–1377. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22660804
- Roebuck-Spencer TM, Yarboro C, Nowak M, et al. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis Rheumatism. 2006 Jun;55(3):434–441. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16739211
- Watad A, Tiosano S, Bragazzi N, et al. Epilepsy among systemic lupus erythematosus patients: insights from a large database analysis. Neuroepidemiology. 2018;50(1–2):1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29208845 https://www.karger.com/Article/FullText/485136
- Adelöw C, Andersson T, Ahlbom A, et al. Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: a populationbased casecontrol study. Epilepsy Res. 2012 Sep;101(3):284–287. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22575230 http://linkinghub.elsevier.com/retrieve/pii/S0920121112001003
- Appenzeller S, Cendes F, Costallat LTL. Epileptic seizures in systemic lupus erythematosus. Neurology. 2004 Nov;63(10):1808–1812. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15557494
- Cieslinski JZ, Skare TL, Nisihara R, et al. Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia and seizure. Lupus. 2018 Mar;27(3):372–379.
- Huang X, Magder LS, Petri M. Predictors of incident seizure in systemic lupus erythematosus. J Rheumatol. 2016 Mar;43(3):565–575. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26773115
- Hawro T, Bogucki A, Krupin´ska-Kun M, et al. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLOS ONE. 2015 Mar;10(3):e0119911. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25781014 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4362944
- Ramsey-Goldman R, Alarcón G, McGwin G, et al. Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort. Lupus. 2008 Mar;17(3):177–184. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18372357 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2787620
- Karaaslan Z, Ekizolu E, Tektürk P, et al. Investigation of neuronal auto-antibodies in systemic lupus erythematosus patients with epilepsy. Epilepsy Res. 2017 Jan;129:132–137. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28043063 http://linkinghub.elsevier.com/retrieve/pii/S0920121116303898
- Kampylafka EI, Alexopoulos H, Fouka P, et al. Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations. Lupus. 2016 Oct;25(11):1260–1265. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26923281
- Devarapu SK, Anders HJ. Toll-like receptors in lupus nephritis. J Biomed Sci. 2018 Apr;25(1):35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29650017 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5898010
- Namjou B, Kothari PH, Kelly JA, et al. Evaluation of the TREX1 gene in a large multiancestral lupus cohort. Genes Immun. 2011 Jun;12(4):270–279. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21270825 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3107387
- Hanly JG, Li Q, Su L, et al. Cerebrovascular events in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2018 Jan;70:1478–1487. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29316357 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6033693
- Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002 Apr;58(8):1214–1220. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11971089
- Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003 May;30(5):985–992. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12734893
- Szalai AJ, Alarco GS, Calvo-Ale J, et al. Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. Rheumatology. 2005;44:864–868. Available from: https://academic.oup.com/rheumatology/articleabstract/44/7/864/1788321
- Svenungsson E, Gustafsson J, Leonard D, et al. A STAT4 risk allele is associated with ischaemic cerebrovascular events and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2010 May;69(5):834–840. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19762360
- Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatism. 1997 Sep;40(9):1725. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9324032
- Pego-Reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology. 2008 Aug;47(10):1498–1502. Available from: https://academic.oup.com/rheumatology/articlelookup/doi/10.1093/rheumatology/ken260
- Costallat BL, Ferreira DM, Costallat LTL, et al. Myelopathy in systemic lupus erythematosus: clinical, laboratory, radiological and progression findings in a cohort of 1,193 patients. Rev Bras Reumatologia (English Edition). 2016 May;56(3):240–251. Available from: https://www.sciencedirect.com/science/article/pii/S2255502116000432?via%3Dihub
- Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002 Aug;59(4):499–505. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12236201
- D’Cruz DP, Mellor-Pita S, Joven B, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol. 2004 Feb;31(2):280–285. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14760797
- Kovacs B, Lafferty TL, Brent LH, et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis. 2000 Feb;59(2):120–124. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10666167 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1753077
- Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol. 1995 May;242(5):326–331. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7643142
- Birnbaum J, Petri M, Thompson R, et al. Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheumatism. 2009 Nov;60(11):3378–3387. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19877037
- Saison J, Costedoat-Chalumeau N, Maucort-Boulch D, et al. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients. Lupus. 2015 Jan;24(1):74–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25117654 http://journals.sagepub.com/doi/10.1177/0961203314547795
- Li XY, Xiao HB, Pai P. Myelitis in systemic lupus erythematosus. J Clin Neurosci. 2017 Oct;44:18–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28694045 http://linkinghub.elsevier.com/retrieve/pii/S0967586817304058
- Barile L, Lavalle C. Transverse myelitis in systemic lupus erythematosus–the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol. 1992 Mar;19(3):370–372. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1578449
- Mikdashi J, Kennedy S, Krumholz A. Recurrent benign lymphocytic (mollaret) meningitis in systemic lupus erythematosus. Neurologist. 2008 Jan;14(1):43–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18195657 https://insights.ovid.com/crossref?an=00127893-200801000-00010
- Baizabal-Carvallo JF, Delgadillo-M´arquez G, Estan˜ol B, et al. Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus. Eur Neurol. 2009;61(3):143–148. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19092250 https://www.karger.com/Article/FullText/186504
- Kim JM, Kim KJ, Yoon HS, et al. Meningitis in Korean patients with systemic lupus erythematosus: analysis of demographics, clinical features and outcomes; experience from affiliated hospitals of the Catholic University of Korea. Lupus. 2011 Apr;20(5):531–536.
- Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, et al. Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol. 2008 Nov;27(11):1377–1385. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18481154
- Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore). 2006 Jul;85(4):221–228. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16862047 https://insights.ovid.com/crossref?an=00005792-200607000-00004
- Appenzeller S, Rondina JM, Li LM, et al. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheumatism. 2005 Sep;52(9):2783–2789. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16142703
- Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001 Aug;57(3):496–500. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11502919
- Schenatto CB, Xavier RM, Bredemeier M, et al. Raised serum S100B protein levels in neuropsychiatric lupus. Ann Rheum Dis. 2006 Jun;65(6):829–831. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16699054 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1798174
- Piga M, Chessa E, Peltz MT, et al. Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis. Autoimmun Rev. 2017 Mar;16(3):244–252. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28159705
- Magro Checa C, Cohen D, Bollen ELEM, et al. Demyelinating disease in SLE: is it multiple sclerosis or lupus? Best Pract Res Clin Rheumatol. 2013 Jun;27(3):405–424. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1521694213000624
- Miller D, Weinshenker B, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler J. 2008 Nov;14(9):1157–1174.
- Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014 Feb;48–49:134–142. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24524923 http://linkinghub.elsevier.com/retrieve/pii/S0896841114000250
- Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm. 2013 Nov;120(11):1579–1589. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23580159
- Baizabal-Carvallo JF, Alonso-Juarez M, Koslowski M. Chorea in systemic lupus erythematosus. J Clin Rheumatol. 2011 Mar;17(2):69–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21325962 http://content.wkhealth.com/linkback/openurl?sid=WKPTLP: landingpage{\&}an=00124743-201103000-00004
- Niu N, Cui R. Glucose hypermetabolism in contralateral basal ganglia demonstrated by serial FDG PET/CT scans in a patient with SLE chorea. Clin Nucl Med. 2017 Jan;42(1):64–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27819860
- Oomatia A, Fang H, Petri M, et al. Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period. Arthritis Rheumatol. 2014 Apr;66(4):1000–1009. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24757151
- Toledano P, Orueta R, Rodrıguez-Pintó I, et al. Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre. Autoimmun Rev. 2017 Jul;16(7):750–755. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28483540 http://linkinghub.elsevier.com/retrieve/pii/S1568997217301337
- Xianbin W, Mingyu W, Dong X, et al. Peripheral neuropathies due to systemic lupus erythematosus in China. Medicine (Baltimore). 2015 Mar;94(11):e625. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25789954 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4602487 https://insights.ovid.com/crossref?an=00005792-201503030-00013
- Handa R, Deepak KK, Bhatia M, et al. Autonomic dysfunction in systemic lupus erythematosus. Rheumatol Int. 2006 Jul;26(9):837–840. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16365754
- Straub RH, Zeuner M, Lock G, et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J Rheumatol. 1996 Jan;23(1):87–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8838514
- Vaiopoulos G, Sfikakis PP, Kapsimali V, et al. The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J. 1994 Oct;70(828):741–745. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7831174 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2397764
- Sthoeger Z, Neiman A, Elbirt D, et al. High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study. Am J Med Sci. 2006 Jan;331(1):4–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16415656
- Bhinder S, Majithia V, Harisdangkul V. Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidentaltwo case reports and review of the literature. Clin Rheumatol. 2006 Jul;25(4):555–556. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16328087
- Tamer S, Gokce Gunes H, Gokcal E, et al. Coexistence of autoimmune diseases and autoantibodies in patients with myasthenia gravis. Neurol India. 2016;64(1):45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26754991 http://www.neurologyindia.com/text.asp?2016/64/1/45/173638
- Jallouli M, Saadoun D, Eymard B, et al. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature. J Neurol. 2012 Jul;259(7):1290–1297. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22160434
- Bekircan-Kurt CE, Tuncer Kurne A, Erdem-Ozdamar S, et al. The course of myasthenia gravis with systemic lupus erythematosus. Eur Neurol. 2014;72(5–6):326–329. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25323839 https://www.karger.com/Article/FullText/365568
- Budhoo A, Mody GM. The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus. Clin Rheumatol. 2015 Dec;34(12):2127–2134. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26298534
- Lai CC, Chen WS, Chang YS, et al. Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus. Arthritis Care Res. 2013;65:1766–1774. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.22047
- Magnano MD, Bush TM, Herrera I, et al. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2006 Jun;35(6):396–402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16765717 http://linkinghub.elsevier.com/retrieve/pii/S0049017206000138
- Ferreira TS, Reis F, Appenzeller S. Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus. Lupus. 2016;25(12):1369–1376.
- Leroux G, Sellam J, Costedoat-Chalumeau N, et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus. 2008 Feb;17(2):139–147. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18250139
- Jung S, Moon SJ, Kwok SK, et al. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus. 2013;22(9):885–891. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23846231 http://journals.sagepub.com/doi/10.1177/0961203313496341
- Merayo-Chalico J, Apodaca E, Barrera-Vargas A, et al. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study. J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):287–294. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25804426
- Merayo-Chalico J, Barrera-Vargas A, Jua´rez-Vega G, et al. Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome. Clin Exp Immunol. 2018 May;192(2):165–170. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29271478 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5904707
- Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep. 2011 Jun;15(3):193–200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21286866 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3086960
- Omdal R, Mellgren SI, Gøransson L, et al. Small nerve fiber involvement in systemic lupus erythematosus: a controlled study. Arthritis Rheumatism. 2002 May;46(5):1228–1232. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12115228
- Pons-Estel BA, Bonfa E, Soriano ER, et al. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American group for the study of lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-pan-American league of associations of rheumatology (PANLAR). Ann Rheum Dis. 2018 Nov;77(11):1549–1557. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30045853
- Bertsias G, Ioannidis JPA, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics. Ann Rheum Dis. 2008 Feb;67(2):195–205. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17504841
- Bertsias GK, Jpa I, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010 Dec;69(12):2074–2082. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20724309
- Barile-Fabris L, Ariza-Andraca R, Olgu´ın-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005 Apr;64(4):620–625. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15769918 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1755456
- Stojanovich L, Stojanovich R, Kostich V, et al. Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study). Lupus. 2003 Jan;12(1):3–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12587819
- Neuwelt CM. The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Ther Apheresis Dialysis. 2003 Apr;7(2):173–182. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12918940
- Bartolucci P, Brechignac S, Cohen P, et al. Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients. Lupus. 2007 Oct;16(10):817–822. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17895305
- Levy Y, Sherer Y, Ahmed A, et al. A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response. Lupus. 1999 Nov;8(9):705–712. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10602441
- Milstone AM, Meyers K, Elia J. Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature. Clin Rheumatol. 2005 Aug;24(4):394–397. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15662488
- Vina ER, Fang AJ, Wallace DJ, et al. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. Semin Arthritis Rheum. 2005 Dec;35(3):175–184. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16325658 http://linkinghub.elsevier.com/retrieve/pii/S0049017205001733
- Tokunaga M, Saito K, Kawabata D, et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis. 2006 Sep;66(4):470–475. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17107983 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1856059
- Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995 Apr;332(15):993–997. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7885428
- Muñoz-Rodriguez FJ, Font J, Cervera R, et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum. 1999 Dec;29(3):182–190. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10622682
- Tektonidou MG, Ioannidis JP, Boki KA, et al. Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. Qjm. 2000 Aug;93(8):523–530. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10924534
- Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheumatism. 2007 Dec;57(8):1487–1495. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18050167
- Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore). 1997 May;76(3):203–212. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9193455
- Heinlein AC, Gertner E. Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus. 2007 Oct;16(10):823–826. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17895306
- Tarr T, Lakos G, Bhattoa HP, et al. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus. 2007 Jan;16(1):39–45.
- Hereng T, Lambert M, Hachulla E, et al. Influence of aspirin on the clinical outcomes of 103 antiphospholipid antibodies-positive patients. Lupus. 2008 Jan;17(1):11–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18089677
- Tektonidou MG, Laskari K, Panagiotakos DB, et al. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Care Res (Hoboken). 2008 Dec;61(1):29–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19116963
- Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003 Sep;349(12):1133–1138. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13679527
- Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005;3(5):848–853. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15869575